Drug Trial Radar · NCT06300307
Study of ATX-01 in Participants With DM1
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
56
Planned (sponsor's estimate)
Start
Oct 15, 2024
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- ARTHEx Biotech S.L.Industry
- Sponsor type
- Industry
- First posted
- Mar 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to test ATX-01 in participants with myotonic dystrophy type 1 (DM1). The main question it aims to answer is if ATX-01 is safe and well tolerated. The trial will compare the safety and tolerability of ATX-01 and a matching placebo. There will be a single-ascending dose part of the trial and a multiple-ascending dose part. In the single-ascending dose, participants will receive one dose of ATX-01 or placebo. In the multiple-ascending dose part, participants will receive three doses of ATX-01 or placebo. ATX-01 is a novel anti-miR (synthetic single stranded oligonucleotide) that inhibits a microRNA called miR-23b.
Conditions
- Myotonic Dystrophy 1
Interventions
ATX-01Drug
Solution for infusion
PlaceboDrug
Solution for infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse eventsTime frame: Up to 120 days
Locations
12 sites in 7 countries. Site status is shown where the registry gives one.
UCLA
Los Angeles, California · Recruiting
University of Florida
Gainesville, Florida · Recruiting
University of Iowa Health Care - Department of Neurology
Iowa City, Iowa · Recruiting
University of Kansas Medical Center, Department of Neurology
Fairway, Kansas · Recruiting
Virginia Commonwealth University
Richmond, Virginia · Recruiting
Centre Intégré Universitaire de Santé et Services Sociaux du Saguenay-Lac-St-Jean
Chicoutimi, Quebec, Canada · Recruiting
Institute of Myology
Paris, France · Recruiting
The NeMO Clinical Center in Milan, Neurorehabilitation Unit, University of Milan
Milan, Italy · Recruiting
Fondazione Policlinico A. Gemelli- IRCCS
Rome, Italy · Recruiting
Radboudumc
Nijmegen, Netherlands · Recruiting
Hospital Universitario Donostia
Donostia / San Sebastian, Spain · Recruiting
St. George's University Hospital
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.